Female Genital Schistosomiasis and HIV: Research Urgently Needed to Improve Understanding of the Health Impacts of This Important Coinfection.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
15 04 2019
Historique:
pubmed: 8 2 2019
medline: 19 12 2019
entrez: 8 2 2019
Statut: ppublish

Résumé

Evidence suggests that there are important interactions between HIV and female genital schistosomiasis (FGS) that may have significant effects on individual and population health. However, the exact way they interact and the health impacts of the interactions are not well understood. In this article, we discuss what is known about the interactions between FGS and HIV, and the potential impact of the interactions. This includes the likelihood that FGS is an important health problem for HIV-positive women in Schistosoma-endemic areas potentially associated with an increased risk of mortality, cancer, and infertility. In addition, it may be significantly impacting the HIV epidemic in sub-Saharan Africa by making young women more susceptible to HIV. We call for immediate action and argue that research is urgently required to address these knowledge gaps and propose a research agenda to achieve this.

Identifiants

pubmed: 30730357
doi: 10.1097/QAI.0000000000001957
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

489-493

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Auteurs

Daniel P OʼBrien (DP)

Manson Unit, Médecins Sans Frontières, London, United Kingdom.
Department of Infectious Diseases, University Hospital Geelong, Geelong, Australia.
Department of Medicine and Infectious Diseases, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.

Nathan Ford (N)

HIV Department, World Health Organization, Geneva, Switzerland.

Amadou G Djirmay (AG)

Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland.

Alexandra Calmy (A)

HIV Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.

Marco Vitoria (M)

HIV Department, World Health Organization, Geneva, Switzerland.

Tomas O Jensen (TO)

Medical Department, Médecins Sans Frontières, Paris, France.

Vanessa Christinet (V)

Centre International de Recherches, d'Enseignements et de Soins en milieu tropical (CIRES), Akonolinga, Cameroon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH